In Vivo Analysis of the Regeneration Capacity and Immune Response to Xenogeneic and Synthetic Bone Substitute Materials

Int J Mol Sci. 2022 Sep 13;23(18):10636. doi: 10.3390/ijms231810636.

Abstract

Although various studies have investigated differences in the tissue reaction pattern to synthetic and xenogeneic bone substitute materials (BSMs), a lack of knowledge exists regarding the classification of both materials based on the DIN ISO 10993-6 scoring system, as well as the histomorphometrical measurement of macrophage subtypes within their implantation beds. Thus, the present study was conducted to analyze in vivo responses to both xenogeneic and synthetic bone substitute granules. A standardized calvaria implantation model in Wistar rats, in combination with established scoring, histological, histopathological, and histomorphometrical methods, was conducted to analyze the influence of both biomaterials on bone regeneration and the immune response. The results showed that the application of the synthetic BSM maxresorb® induced a higher pro-inflammatory tissue response, while the xenogeneic BSM cerabone® induced a higher anti-inflammatory reaction. Additionally, comparable bone regeneration amounts were found in both study groups. Histopathological scoring revealed that the synthetic BSM exhibited non-irritant scores at all timepoints using the xenogeneic BSM as control. Overall, the results demonstrated the biocompatibility of synthetic BSM maxresorb® and support the conclusion that this material class is a suitable alternative to natural BSM, such as the analyzed xenogeneic material cerabone®, for a broad range of indications.

Keywords: DIN ISO 10993-6; bone grafts; bone regeneration; immune response; immunohistochemical staining; macrophage polarization; synthetic graft; xenograft.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents
  • Biocompatible Materials / pharmacology
  • Bone Regeneration
  • Bone Substitutes* / pharmacology
  • Calcium Phosphates
  • Hydroxyapatites
  • Immunity
  • Rats
  • Rats, Wistar

Substances

  • Anti-Inflammatory Agents
  • Biocompatible Materials
  • Bone Substitutes
  • Calcium Phosphates
  • Hydroxyapatites
  • cerabone
  • maxresorb

Grants and funding

This work was supported by the Federal Ministry of Education and Research (BMBF, Germany, FKZ: 13GW0400A and C); and the State Ministry of Baden-Württemberg for Economic Affairs, Labour and Tourism. Additionally, the authors gratefully acknowledge the funding by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) for the subproject 6 within the Research Unit 5250 “Permanent and bioresorbable implants with tailored functionality” (No. 449916462).